Navidea Biopharmaceuticals Inc. has filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. The filing aims to restructure the company’s financial obligations while allowing limited operations to continue. Navidea plans to use this process to explore strategic alternatives, safeguard assets, and ensure fair treatment of creditors.

Read more at Nasdaq: Navidea Biopharmaceuticals Files For Chapter 11 Bankruptcy Protection